Tuesday, 17 November 2026 · Europe
EUR/USD 1.099 EUR/GBP 0.833 EUR/CHF 0.9233 EUR/PLN 4.404 All rates →
Sign in · Join
EUROPES The European Report
European Edition Tuesday, 17 November 2026
LATEST 46 people injured after two trains collide in Prague Le Flash →
Tech & Startups

Max Hodak’s Science raises $400m to take its sight-restoring chip to the US

Max Hodak’s Science raises $400m to take its sight-restoring chip to the US

Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, has raised a $400m Series D. The round values it at $3.5bn, a person familiar with the deal told TechCrunch. Backers include Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare and Y Combinator, Science said in a blog post. It has now […] This story continues at The Next Web

Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, has raised a $400m Series D. The round values it at $3.5bn, a person familiar with the deal told TechCrunch .

Backers include Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare and Y Combinator, Science said in a blog post . It has now raised more than $900m since 2021.

Science’s first product, PRIMA, is a wearable and implantable chip for people with age-related macular degeneration. Science says it is the first brain-computer interface with a CE mark to restore “form vision”. That is the ability to read letters, numbers and words.

The round comes a few months after PRIMA’s launch in Europe , where it is available in Germany. Science will use the money to make PRIMA available across more of Europe and to prepare a US launch.

In the US, Science is seeking FDA approval through the Humanitarian Device Exemption, a route for rare conditions. It persuaded the FDA that advanced macular degeneration in both eyes is uncommon enough to qualify, TechCrunch reported. Science is also testing PRIMA in patients with Stargardt disease, another cause of blindness.

Science will also spend more on its biohybrid programme. It is a neural interface that joins engineered neurons to the brain’s own circuits. It is designing the first human trials with Yale neurosurgery professor Murat Günel, TechCrunch reported.

Hodak co-founded Neuralink in 2016 and was its president for four years before starting Science. The new money will also expand Science’s research, manufacturing and operations.

Other brain-interface startups have raised smaller rounds. Bridge Neurotech raised $13.5m in October for an ultrasound-based interface. In Europe, Barcelona’s INBRAIN Neuroelectronics is developing graphene brain implants .

More from Tech & Startups